Intelligent Bio Solutions Inc. (NASDAQ:INBS) Short Interest Up 19.1% in March

Intelligent Bio Solutions Inc. (NASDAQ:INBS) saw a significant increase in short interest in the month of March. As of March 31st, there was short interest totalling 538,900 shares, an increase of 19.1% from the March 15th total of 452,300 shares. Based on an average daily volume of 206,300 shares, the short-interest ratio is presently 2.6 days. Currently, 8.1% of the shares of the company are sold short.

Intelligent Bio Solutions Stock Up 2.5 %

INBS opened at $1.24 on Wednesday. Intelligent Bio Solutions has a 12 month low of $1.00 and a 12 month high of $3.04. The company has a 50 day moving average of $1.81 and a 200 day moving average of $1.64.

Intelligent Bio Solutions (NASDAQ:INBS) last announced its quarterly earnings results on Thursday, February 13th. The company reported ($0.50) earnings per share for the quarter. The company had revenue of $610 billion during the quarter. Intelligent Bio Solutions had a negative net margin of 323.79% and a negative return on equity of 146.03%. As a group, equities analysts forecast that Intelligent Bio Solutions will post -1.25 earnings per share for the current fiscal year.

About Intelligent Bio Solutions

Intelligent Bio Solutions Inc, a medical technology company, developing non-invasive, real-time monitoring, and diagnostic tests for patients and their primary health practitioners. It offers saliva glucose biosensor for diabetes management that measures glucose in saliva. The company also provides intelligent fingerprinting drug screening system, a revolutionizing portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields; and biosensor platform for biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities.